Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Cardiol ; 93(8): 1012-6, 2004 Apr 15.
Article in English | MEDLINE | ID: mdl-15081445

ABSTRACT

Impaired vascular endothelial function may be an important mechanism linking obesity to increased cardiovascular risk. We investigated whether short-term weight loss improves conduit artery endothelial dysfunction in overweight adults. Forty-three otherwise healthy overweight patients with a body mass index > or =27 kg/m(2) completed an open-label 3-month trial consisting of a calorie-restricted diet and 120 mg of orlistat taken 3 times daily with meals. Endothelial function and parameters of the metabolic syndrome were measured before and after intervention. Subjects lost 6.6 +/- 3.4% of their body weight. Low-density lipoprotein cholesterol, low-density lipoprotein concentration, fasting insulin, and leptin decreased significantly (all p <0.009), and C-reactive protein decreased (p = 0.22). Conduit vascular function did not change as assessed by flow-mediated dilation (3.86 +/- 3.54 vs 3.74 +/- 3.78%, p = 0.86) and nitroglycerin-mediated dilation (17.18 +/- 5.89 vs 18.87 +/- 7.11%, p = 0.13) of the brachial artery. A moderate degree of weight reduction over 3 months improved the metabolic syndrome profile but not the vascular dysfunction associated with uncomplicated obesity.


Subject(s)
Endothelium, Vascular/pathology , Metabolic Syndrome/metabolism , Obesity/therapy , Weight Loss , Adolescent , Adult , Anti-Obesity Agents/therapeutic use , C-Reactive Protein/analysis , Cholesterol, LDL/blood , Diet, Reducing , Female , Humans , Insulin/blood , Lactones/therapeutic use , Leptin/blood , Lipoproteins, LDL/blood , Male , Middle Aged , Orlistat
SELECTION OF CITATIONS
SEARCH DETAIL
...